Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Vilin Bio Med Ltd

NSE: VILINBIO · Pharmaceuticals & Biotechnology · 5 announcements

Share price
₹51.50
Market cap
₹78.54 Cr
Revenue (annual)
₹42.26 Cr
Net profit (annual)
₹1.93 Cr
P/E (TTM)
40.7×Sector 50.4×
Promoter holding
56.65%-2.92% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

18:35 IST NSE
Merger & Restructuring

Vilin Bio Med Merger & Restructuring

Vilin Bio Med Limited announced an NCLT-convened meeting on October 15, 2026, to vote on a Scheme of Arrangement with Chemgenix Laboratories Private Limited.